Dermatology Partnering Terms and Agreements


Published on

Market Research Reports, Inc. has announced the addition of “Dermatology Partnering Terms and Agreements” research report to their offering. See more at-

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Dermatology Partnering Terms and Agreements

  1. 1. Category : Pharma & Healthcare All logos and Images mentioned on this slide belong to their respective owners.
  2. 2. Introduction to Report  Launch Date: July 1, 2014  Number of Pages: 942  Geography Coverage: Global  Available Format: PDF Price For Single User License: USD 2,995 Price For Site License: USD 8,995 Price For Global User License: USD 14,995 Delivery Time: Within 24 Hours (During Working Days)
  3. 3. About the Report The Dermatology Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter dermatology partnering deals. The majority of deals are discovery, preclinical or development stage whereby the licensee obtains a right or an option right to license the licensors bacterials technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
  4. 4. Research Findings The initial chapters of this report provide an orientation of dermatology dealmaking and business activities. Chapter 1 provides an introduction to the report. Chapter 2 provides an overview of the trends in dermatology dealmaking since 2009 covering trends by year, deal type, stage of development, technology type and therapeutic indication. Chapter 3 provides a review of the leading dermatology deals since 2009. Deals are listed by headline value, signed by bigpharma, most active bigpharma, and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
  5. 5. Research Findings Continues… Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies with a brief summary followed by a comprehensive listing of dermatology deals, as well as contract documents available in the public domain. Chapter 5 provides comprehensive access to all dermatology deals since 2009 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Chapter 6 provides a comprehensive directory of all dermatology partnering deals signed and announced since 2009. The chapter is organized by specific dermatology therapy focus.
  6. 6. Key Benefits: In-depth understanding of dental deal trends since 2009 Access dental deal headline, upfront, milestone and royalty data Research hundreds of actual contracts between dermatology partner companies Comprehensive access to over 1500 links to actual dermatology deals entered into by the world’s biopharma companies Indepth review of dental deals entered into by the leading fifty bigpharma companies Benchmark the key deal terms companies have agreed in previous deals Identify key terms under which companies partner dermatology opportunities Uncover companies actively partnering dermatology opportunities
  7. 7. This Report Includes: Trends in dermatology dealmaking in the biopharma industry since 2009 Analysis of dermatology deal structure Access theadline, upfront, milestone and royalty data Access thundreds of dermatology deal contract documents Comprehensive access tover 1500 dermatology deal records The leading dermatology deals by value since 2009 Most active dermatology dealmakers since 2009
  8. 8. Report Coverage 1. Executive Summary 2. Introduction 3. Trends in dermatology dealmaking 4. Leading Dermatology deals 5. Big pharma dermatology deals 6. Big biotech dermatology deals 7. ermatology partnering contracts directory 8. Dermatology dealmaking by therapeutic target 9. Appendices For more details regarding Report coverage see the last slide All logos and Images mentioned on this slide belong to their respective owners.
  9. 9. Company Coverage (Partial List) 1. Abbott 2. Actavis 3. Actavis (Acquired by Watson) 4. Allergan 5. Amgen 6. Astellas 7. AstraZeneca 8. Baxter International 9. Bayer 10.Bristol-Myers Squibb 11.Celgene 12.Eli Lilly 13.Endo Pharmaceuticals 14.Forest Laboratories For more details regarding Report coverage see the last slide All logos and Images mentioned on this slide belong to their respective owners.
  10. 10. Custom Research:  Are you an industry professional, entrepreneur, venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research. For Any Customization Related query Visit IdeaCenter @
  11. 11. How To Buy This Report? Visit following URL to see Table of Content and purchase this publication: About Market Research Reports, Inc. Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”. Contact : Amitava Sen Email : Phone: +1 302-703-7787 (USA) +91-8762746600 (India)